Rhabdomyolysis, When Observed With High-Dose Interferon-Alfa (HDI) Therapy, Does Not Always Exclude Resumption of HDI
Year: 2001
Type: article
Source: Journal of Clinical Oncology
Institution: UPMC Hillman Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2338635236
